Home›Explore peptides›Peptide or biologic?
Peptide or biologic: where FDA draws the line
For US regulators the line is 40 amino acids. A chain of more than 40 (with a defined sequence) is a “protein,” which the statute treats as a biological product; FDA’s rule treats a “peptide” as a separate, generally shorter and simpler chain.
On this page
In brief
Should you care? Mostly if you read about peptide medicines and wonder why some are licensed as biologics and others approved as drugs. It is a regulatory size rule, not a measure of safety, quality or evidence.The short version
The short answer
In the United States the dividing line is a number. FDA’s final rule defines “protein” as any alpha amino acid polymer with a specific, defined sequence that is greater than 40 amino acids in size.1 As amended by the Biologics Price Competition and Innovation Act of 2009 (the BPCI Act) and the Further Consolidated Appropriations Act, 2020, the statutory definition of a biological product includes a protein, and FDA states that every polymer meeting its “protein” definition falls within that definition. FDA’s rule describes a peptide as an amino acid chain that is generally shorter and simpler than a protein.1
The 40-amino-acid rule
| Chain size | FDA term | How it is regulated |
|---|---|---|
| More than 40 amino acids, with a specific defined sequence | Protein1 | A biological product under the statute1 |
| 40 or fewer amino acids | Not a “protein” under the rule; FDA’s rule treats “peptide” as a separate, generally shorter and simpler chain1 | Outside the rule’s definition of a biological product “protein”; how a particular product is regulated depends on the product |
FDA’s rule acknowledges there is no clear scientific consensus on a particular number of amino acids separating a peptide from a protein, and says it adopted a “bright-line rule” for regulatory clarity.1 That is why the figure differs from the looser size ranges used in chemistry, such as those on Peptides vs proteins vs amino acids: the 40 is a legal interpretation for regulatory purposes, not a discovery about molecules.
How the count works: insulin
When two or more amino acid chains are associated with each other in a manner that occurs in nature, FDA adds the amino acids in each chain together. FDA’s own worked example is insulin: two chains of 21 and 30 amino acids, so 51 in total, which exceeds 40, so insulin is a “protein” as FDA interprets it.1 A small peptide such as the three-amino-acid copper peptide GHK-Cu is far below the line. For the medicine itself, see Insulin.
Why it matters, and what it does not tell you
The label matters because it decides how a product is regulated. The BPCI Act set a ten-year transition period, ending 23 March 2020, for certain products previously approved as drugs, as the rule describes.1
- It is not a quality or evidence grade. It says nothing about whether a peptide works or is safe.
- It does not say whether a product is approved. Being a “peptide” or a “protein” under this rule does not tell you whether a given product is approved, compounded or unapproved. For the status of specific compounds, use the legal status tracker.
- It is a US rule. Other regulators use their own definitions.
- It is separate from supplements and cosmetics. For those categories, see Is a peptide supplement approved by the FDA? and Are peptide skincare products FDA-approved?
As of this review, and what would change it
As of 30 September 2026
This page follows FDA’s final rule “Definition of the Term ‘Biological Product’” (85 Fed. Reg. 10057, 21 February 2020, effective 23 March 2020). We found no later amendment of the rule.
We will revise and date this page if FDA amends that rule or issues guidance on the peptide/protein line, if Congress changes the statutory definition of a biological product, or if a reader shows us an error (use the “Report an error” topic on About).
What you can do next
References
- U.S. Food and Drug Administration, final rule, “Definition of the Term ‘Biological Product’,” 85 Fed. Reg. 10057 (21 February 2020), 21 CFR Part 600, effective 23 March 2020. govinfo.gov